Co-expression analysis was done with neurotransmitters and neuropeptides: TH, NPY, and 5-HT (in the stomach) and CGRP, Calb1, Nos1 and VIP (in the small intestine). Co-expression was seen with all.
Co-expression analysis was done with neurotransmitters and neuropeptides: TH, NPY, and 5-HT (in the stomach) and CGRP, Calb1, Nos1 and VIP (in the small intestine). Co-expression was seen with Th, partial co-expression with 5-HT and no co-expression with the rest.
Co-expression analysis was done with neurotransmitters and neuropeptides: TH, CGRP, Calb1, Nos1, NPY, 5-HT and VIP (in the stomach). Partial co-expression was seen with with TH, Calb1, and NPY and no co-expression with the rest.
Co-expression analysis was done with neurotransmitters and neuropeptides: TH, NPY, and 5-HT (in the stomach) and CGRP, Calb1, Nos1 and VIP (in the small intestine). Co-expression was seen with Th, NPY, 5-HT and VIP and partial co-expression was seen with CGRP, Calb1 and Nos1.
Co-expression analysis was done with neurotransmitters and neuropeptides: TH, NPY, and 5-HT (in the stomach) and CGRP, Calb1, Nos1 and VIP (in the small intestine). Partial co-expression was seen with with CGRP, 5-HT, and VIP and no co-expression with the rest.
Co-expression analysis was done with neurotransmitters and neuropeptides: TH, NPY, and 5-HT (in the stomach) and CGRP, Calb1, Nos1 and VIP (in the small intestine). Co expression was seen with Th, CGRP, 5-HT and VIP, partial co-expression with Calb1 and Nos1, and no co-expression with NPY.